Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002 Sep. 17(3):375-87. [QxMD MEDLINE Link].
Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev. 2008 Dec. 226:57-79. [QxMD MEDLINE Link].
Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 2011 May. 71(5):701-7. [QxMD MEDLINE Link].
Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol. 2004 May. 16(5):685-95. [QxMD MEDLINE Link].
He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol. 2006 Nov 15. 177(10):6852-8. [QxMD MEDLINE Link].
Sousa-Pinto B, Correia C, Gomes L, Gil-Mata S, Araújo L, Correia O, et al. HLA and Delayed Drug-Induced Hypersensitivity. Int Arch Allergy Immunol. 2016. 170 (3):163-79. [QxMD MEDLINE Link]. [Full Text].
Illing PT, Mifsud NA, Purcell AW. Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions. Curr Opin Immunol. 2016 Oct. 42:31-40. [QxMD MEDLINE Link].
Ostrov DA, Grant BJ, Pompeu YA, et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A. 2012 Jun 19. 109(25):9959-64. [QxMD MEDLINE Link]. [Full Text].
Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood. 2013 Mar 28. 121(13):2402-14. [QxMD MEDLINE Link]. [Full Text].
Hirahara K, Poholek A, Vahedi G, Laurence A, Kanno Y, Milner JD, et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. J Allergy Clin Immunol. 2013 May. 131(5):1276-87. [QxMD MEDLINE Link]. [Full Text].
Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol. 2010 May 1. 184(9):4880-8. [QxMD MEDLINE Link].
Chen J, Liu X. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell Immunol. 2009. 254(2):85-90. [QxMD MEDLINE Link].
Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A. 2010 Oct 26. 107(43):18581-6. [QxMD MEDLINE Link].
Frenzel DF, Weiss JM. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy. Expert Rev Clin Immunol. 2011 Jan. 7(1):93-109. [QxMD MEDLINE Link].
Frenzel DF, Weiss JM. Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy. Expert Rev Clin Immunol. 2011 Jan. 7(1):93-109. [QxMD MEDLINE Link].
Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008 Dec. 122(6):1043-51; quiz 1052-3. [QxMD MEDLINE Link].
Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008 Apr 10. 452(7188):773-6. [QxMD MEDLINE Link].
Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010 Sep. 126(3):611-7.e1. [QxMD MEDLINE Link].
Unsinger J, Kazama H, McDonough JS, Griffith TS, Hotchkiss RS, Ferguson TA. Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol. 2010 Jun 15. 184(12):6766-72. [QxMD MEDLINE Link].
Romano A, Valluzzi RL, Caruso C, Maggioletti M, Gaeta F. Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis. Curr Allergy Asthma Rep. 2017 Apr. 17 (4):23. [QxMD MEDLINE Link].
Schnuch A, Westphal G, Mössner R, Uter W, Reich K. Genetic factors in contact allergy--review and future goals. Contact Dermatitis. 2011 Jan. 64(1):2-23. [QxMD MEDLINE Link].
Roesler J, Horwitz ME, Picard C, et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr. 2004 Dec. 145(6):806-12. [QxMD MEDLINE Link].
Chantrain CF, Bruwier A, Brichard B, et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant. 2006 Jul. 38(1):75-6. [QxMD MEDLINE Link].
[Guideline] CDC. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep. 2008 Mar 14. 57(10):258-60. [QxMD MEDLINE Link].
Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol. 1999 Jan 1. 162(1):494-502. [QxMD MEDLINE Link].
Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998 May 29. 280(5368):1432-5. [QxMD MEDLINE Link].
Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998 Dec 15. 102(12):2035-40. [QxMD MEDLINE Link].
Askenase PW. Effector and regulatory molecules and mechanisms in delayed type hypersensitivity. Middleton E, et al, eds. Allergy: Principles and Practice. 1998. Vol 1: 323-41.
Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol. 2004 Jan. 4(1):55-66. [QxMD MEDLINE Link].
Chantrain CF, Bruwier A, Brichard B, et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant. 2006 Jul. 38(1):75-6. [QxMD MEDLINE Link].
Chapgier A, Wynn RF, Jouanguy E, et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol. 2006 Apr 15. 176(8):5078-83. [QxMD MEDLINE Link].
de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998 May 29. 280(5368):1435-8. [QxMD MEDLINE Link].
Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest. 1998 Jun 1. 101(11):2364-9. [QxMD MEDLINE Link].
Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004 Dec 11-17. 364(9451):2113-21. [QxMD MEDLINE Link].
Dorman SE, Uzel G, Roesler J, et al. Viral infections in interferon-gamma receptor deficiency. J Pediatr. 1999 Nov. 135(5):640-3. [QxMD MEDLINE Link].
Dupuis S, Doffinger R, Picard C, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000 Dec. 178:129-37. [QxMD MEDLINE Link].
Horwitz ME, Uzel G, Linton GF, et al. Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency. Blood. 2003 Oct 1. 102(7):2692-4. [QxMD MEDLINE Link].
Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localization, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 2000 Dec. 1(8):515-20. [QxMD MEDLINE Link].
Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med. 1996 Dec 26. 335(26):1956-61. [QxMD MEDLINE Link].
Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest. 2000 May. 105(10):1429-36. [QxMD MEDLINE Link].
Jouanguy E, Lamhamedi-Cherradi S, Altare F, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997 Dec 1. 100(11):2658-64. [QxMD MEDLINE Link].
Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet. 1999 Apr. 21(4):370-8. [QxMD MEDLINE Link].
Lammas DA, De Heer E, Edgar JD, et al. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int J Exp Pathol. 2002 Feb. 83(1):1-20. [QxMD MEDLINE Link].
Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996 Dec 26. 335(26):1941-9. [QxMD MEDLINE Link].
Novelli F, Casanova JL. The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev. 2004 Oct. 15(5):367-77. [QxMD MEDLINE Link].
Roesler J, Horwitz ME, Picard C, et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr. 2004 Dec. 145(6):806-12. [QxMD MEDLINE Link].
Rosenzweig SD, Holland SM. Congenital defects in the interferon-gamma/interleukin-12 pathway. Curr Opin Pediatr. 2004 Feb. 16(1):3-8. [QxMD MEDLINE Link].
Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005 Feb. 203:38-47. [QxMD MEDLINE Link].
Schnorr JJ, Cutts FT, Wheeler JG, et al. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine. 2001 Jan 8. 19(11-12):1503-10. [QxMD MEDLINE Link].
Sharma KC, Stevens D, Casey L, Kesten S. Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers. Chest. 2000 Oct. 118(4):1042-8. [QxMD MEDLINE Link].
Vankayalapati R, Wizel B, Samten B, et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis. 2001 Feb 1. 183(3):478-84. [QxMD MEDLINE Link].